Capecitabine Plus Paclitaxel As Front-Line Combination Therapy for Metastatic Breast Cancer: A Multicenter Phase II Study
GRADISHAR, William J, MEZA, Luis A, AMIN, Bipinkumar, SAMID, Dvorit, HILL, Todd, CHEN, Yin-Miao, LOWER, Elyse E, MARCOM, P. Kelly
Published in Journal of clinical oncology (15.06.2004)
Published in Journal of clinical oncology (15.06.2004)
Get full text
Journal Article
Impact of Latino ethnicity on the gut microbiome composition of patients with metastatic renal cell cancer (mRCC)
Barragán Carrillo, Regina, Dizman, Nazli, Ebrahimi, Hedyeh, Meza, Luis A, Bergerot, Paulo Gustavo, Dorff, Tanya B., Hsu, Joann, Zengin, Zeynep Busra, Salgia, Nicholas, Chehrazi-Raffle, Alex, Tripathi, Abhishek, Castro, Daniela V., Mercier, Benjamin, Caporaso, Gregory, Lee, Keehoon, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
77 Impact of CBM588 on gut microbiome composition and dysbiosis in patients receiving frontline immune checkpoint inhibitor (ICI) combinations for metastatic renal cell carcinoma (mRCC)
Dizman, Nazli, Ebrahimi, Hedyeh, Barragan-Carrillo, Regina, Meza, Luis A, Bergerot, Paulo, Dorff, Tanya, BSc, JoAnn Hsu, Zengin, Zeynep, Castro, Daniela, Chehrazi-Raffle, Alex, Triphathi, Abhishek, Trent, Jeffrey, Takahashi, Motomichi, Oka, Kentaro, Higashi, Seiya, Caporaso, Gregory, Lee, Keehoon, Pal, Sumanta K
Published in The oncologist (Dayton, Ohio) (06.08.2024)
Published in The oncologist (Dayton, Ohio) (06.08.2024)
Get full text
Journal Article
Distinct outcomes in Hispanic/Latinx and non-Hispanic/Latinx patients with metastatic renal cell carcinoma (mRCC) treated with first-line ipilimumab plus nivolumab (ipi/nivo)
Ali, Sana, Leong, Sally, Meza, Luis A, Dizman, Nazli, Zengin, Zeynep Busra, Kim, Tane, Pak, Youngju, Onyshchenko, Mykola, Pal, Sumanta K., Chehrazi-Raffle, Alex
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi)
Leong, Sally, Ali, Sana, Zengin, Zeynep Busra, Meza, Luis A, Dizman, Nazli, Ebrahimi, Hedyeh, Govindarajan, Ameish, Castro, Daniela V., Li, Xiaochen, Kim, Tane, Melamed, Sam, Onyshchenko, Mykola, Pal, Sumanta Monty, Chehrazi-Raffle, Alex
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Impact of race and payor status on patterns of utilization of partial and radical nephrectomy in patients with localized renal cell carcinoma (RCC)
Barragan-Carrillo, Regina, Dallas, Kai, Tripathi, Abhishek, Govindarajan, Ameish, Zengin, Zeynep Busra, Meza, Luis A, Philip, Errol James, Castro, Daniela V., Chehrazi-Raffle, Alexander, Chawla, Neal, Hsu, Joann, Dizman, Nazli, Eilber, Karyn, Bergerot, Cristiane Decat, Pal, Sumanta Monty
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Impact of race and payer status on the choice of urinary diversion among patients with localized bladder carcinoma undergoing cystectomy
Tripathi, Abhishek, Barragan-Carrillo, Regina, Philip, Errol James, Govindarajan, Ameish, Chawla, Neal, Castro, Daniela V., Chehrazi-Raffle, Alexander, Dizman, Nazli, Hsu, Joann, Meza, Luis A, Zengin, Zeynep Busra, Bergerot, Cristiane Decat, Eilber, Karyn, Pal, Sumanta Monty, Dallas, Kai
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Prevalence of dietary modification and supplement use in patients with metastatic renal cell carcinoma (mRCC)
Ebrahimi, Hedyeh, Battle, Dena, Zengin, Zeynep Busra, Dizman, Nazli, Meza, Luis A, Castro, Daniela V., Govindarajan, Ameish, Mercier, Benjamin D., Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Tripathi, Abhishek, Liu, Sandy, Vaishampayan, Ulka N., Staehler, Michael D., Pal, Sumanta Monty
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Impact of CBM588 on gut microbiome composition and dysbiosis in patients receiving frontline immune checkpoint inhibitor (ICI) combinations for metastatic renal cell carcinoma (mRCC)
Dizman, Nazli, Ebrahimi, Hedyeh, Barragán Carrillo, Regina, Meza, Luis A, Bergerot, Paulo Gustavo, Dorff, Tanya B., Hsu, Joann, Zengin, Zeynep Busra, Castro, Daniela V., Chehrazi-Raffle, Alex, Tripathi, Abhishek, Trent, Jeffrey M., Takahashi, Motomichi, Oka, Kentaro, Higashi, Seiya, Caporaso, Gregory, Lee, Keehoon, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Distinct cytokines predict response to immunotherapy and targeted therapy in metastatic renal cell carcinoma (mRCC)
Chehrazi-Raffle, Alex, Meza, Luis A, Alcantara, Marice, Salgia, Nicholas, Dizman, Nazli, Bergerot, Paulo Gustavo, Hsu, Joann, Kortylewski, Marcin, Pal, Sumanta K.
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Clinical and molecular characterization of urothelial (UC) vs. small cell carcinoma (SCC) of the urinary tract
Chawla, Neal Shiv, Mercier, Benjamin D., Govindarajan, Ameish, Li, Xiaochen, Castro, Daniela V., Ebrahimi, Hedyeh, Barragan-Carrillo, Regina, Zang, Peter D., LeVee, Alexis Ann, Dizman, Nazli, Hsu, Joann, Meza, Luis A, Zengin, Zeynep Busra, Salgia, Nicholas, Chehrazi-Raffle, Alex, Dorff, Tanya B., Pal, Sumanta Kumar, Tripathi, Abhishek
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC)
Barragan-Carrillo, Regina, Chawla, Neal Shiv, Salgia, Nicholas, Meza, Luis A, Zengin, Zeynep Busra, Li, Xiaochen, Dizman, Nazli, Ebrahimi, Hedyeh, Hsu, Joann, Castro, Daniela V., Mercier, Benjamin D., Dorff, Tanya B., Tripathi, Abhishek, Bergerot, Cristiane Decat, Bergerot, Paulo Gustavo, Chehrazi-Raffle, Alex, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Evolution of the functionality of microbial communities in patients with metastatic renal cell carcinoma (mRCC) receiving cabozantinib (cabo)/nivolumab (nivo) with or without CBM588: A randomized clinical trial
Ebrahimi, Hedyeh, Meza, Luis A, Lee, Keehoon, Malhotra, Jasnoor, Alcantara, Marice, Zengin, Zeynep Busra, Dizman, Nazli, Hsu, Joann, Llamas-Quitiquit, Marian, Castro, Daniela V., Mercier, Benjamin D., Barragan-Carrillo, Regina, Chawla, Neal Shiv, Li, Xiaochen, Liu, Sandy, Chehrazi-Raffle, Alex, Dorff, Tanya B., Frankel, Paul Henry, Tripathi, Abhishek, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Impact of insurance payer status (IS) on practice patterns and overall survival (OS) in patients (pts) with metastatic urothelial carcinoma (mUC)
Mercier, Benjamin D., Tripathi, Nishita, Govindarajan, Ameish, Gebrael, Georges, Narang, Arshit, Li, Xiaochen, Castro, Daniela V., Chehrazi-Raffle, Alex, Dizman, Nazli, Ebrahimi, Hedyeh, Chawla, Neal Shiv, Hsu, Joann, Bergerot, Cristiane Decat, Barragan-Carrillo, Regina, Zengin, Zeynep Busra, Meza, Luis A, Pal, Sumanta Kumar, Agarwal, Neeraj, Tripathi, Abhishek
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Association between thymectomy and incidence of renal cell carcinoma (RCC)
Barragan-Carrillo, Regina, Ebrahimi, Hedyeh, Chawla, Neal Shiv, Salgia, Nicholas, Castro, Daniela V., Chehrazi-Raffle, Alex, Dizman, Nazli, Hsu, Joann, Meza, Luis A, Zengin, Zeynep Busra, LeVee, Alexis Ann, Tripathi, Abhishek, Dorff, Tanya B., Bergerot, Cristiane Decat, Bergerot, Paulo Gustavo, Eilber, Karyn, Dallas, Kai, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
A phase I trial to evaluate the biologic effect of CBM588 ( Clostridium butyricum ) in combination with cabozantinib plus nivolumab for patients with metastatic renal cell carcinoma (mRCC)
Meza, Luis A, Malhotra, Jasnoor, Zengin, Zeynep Busra, Dizman, Nazli, Hsu, Joann, Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Muddasani, Ramya, Govindarajan, Ameish, Castro, Daniela V., Dorff, Tanya B., Lyou, Yung, Frankel, Paul Henry, Pal, Sumanta K.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Changes in perception of immunotherapy over time among patients with advanced genitourinary cancers
Malhotra, Jasnoor, Philip, Errol James, Govindarajan, Ameish, Meza, Luis A, Zengin, Zeynep Busra, Salgia, Sabrina, Muddasani, Ramya, Chawla, Neal Shiv, Castro, Daniela, Chehrazi-Raffle, Alex, Dizman, Nazli, Bergerot, Paulo Gustavo, Hsu, Joann, Dorff, Tanya B., Pal, Sumanta K., Bergerot, Cristiane Decat
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Characteristics associated with common reasons to pursue genomic profiling among patients with metastatic genitourinary cancers
Malhotra, Jasnoor, Philip, Errol James, Govindarajan, Ameish, Salgia, Sabrina, Meza, Luis A, Zengin, Zeynep Busra, Muddasani, Ramya, Chawla, Neal Shiv, Castro, Daniela, Chehrazi-Raffle, Alex, Dizman, Nazli, Bergerot, Paulo Gustavo, Hsu, Joann, Dorff, Tanya B., Pal, Sumanta K., Bergerot, Cristiane Decat
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article